Skip to content
OpenCapital
Get started

PTC Therapeutics PTCT Q3 2025 earnings

Reported November 4, 2025 · After market close

Revenue$211.0MMiss by $70.4M
EPS$0.20Beat by $1.39
Revenue estimate$281.5M
EPS estimate-$1.19

Next report

Jul 30, 2026 (Today)
Revenue estimate$298.6M
EPS estimate$0.24

Financials

Q3 2025

Income statement

See full
Revenue$211.0M+7.2%
Operating income$3.0M+106%
Net income$15.9M+115%
EPS (diluted)$0.20+114%

Balance sheet

See full
Cash & equivalents$672.6M+27.9%
Total debt$410.1M+1.8%
Total equity-$155.8M+85.2%
Total assets$2.6B+43.5%

Cash flow

See full
CapEx$3.4M+560%

Valuation & ratios

Valuation

as of 09/30/25
See full
Market cap$4.88B+71.3%
Enterprise value$4.61B+69.4%
P/E6.5×—
P/S2.7×-0.4×

Profitability

See full
Operating margin43.6%+34.5pp
Net margin42.3%+27.4pp

Returns & leverage

See full
Current ratio2.3×+0.2×

Segments

By product

See full
Translarna$50.7M—
Emflaza$35.2M—
Sephience$19.6M—
Other Products$9.8M—

By segment

See full
Life Science$211.0M+7.2%

Versus estimates

Revenue

Q1 2026$272.6MBeat by $55.1MQ4 2025$164.7MMiss by $114.8M
Q3 2025$211.0MMiss by $70.4M
Q2 2025$178.9MMiss by $12.6MQ1 2025$1.2BBeat by $803.5MQ4 2024$213.2MMiss by $35.8M

Diluted EPS

Q1 2026-$0.03Beat by $0.42Q4 2025-$1.67Miss by $1.46
Q3 2025$0.20Beat by $1.39
Q2 2025-$0.83Beat by $0.24Q1 2025$10.04Beat by $11.12Q4 2024-$0.24Beat by $0.88

Ask the moment PTC Therapeutics reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did PTC Therapeutics report Q3 2025 earnings?
PTC Therapeutics (PTCT) reported Q3 2025 earnings on November 4, 2025 after market close.
What were PTC Therapeutics's Q3 2025 revenue and EPS?
PTC Therapeutics reported revenue of $211.0M and eps of $0.20 for Q3 2025.
Did PTC Therapeutics beat estimates in Q3 2025?
Revenue missed the consensus estimate of $281.5M by $70.4M. EPS beat the consensus estimate of $-1.19 by $1.39.
How did PTC Therapeutics's Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 7.2% from $196.8M a year earlier.
Where can I find PTC Therapeutics's Q3 2025 SEC filings?
You can read the 8-K earnings release (0001070081-25-000026) and the 10-Q periodic report (0001070081-25-000028) directly on SEC EDGAR. The filing index links above go to sec.gov.